Prostate-Cancer Test Not Worth Risk, Panel Says - BusinessWeek

New York Times (blog)

Prostate-Cancer Test Not Worth Risk, Panel Says BusinessWeek By Alex Nussbaum on May 21, 2012 The PSA prostate-cancer test used by half of US men older than 40 carries more risks than benefits and shouldn't be used to diagnose the disease, a US panel said, reaffirming its earlier advice. Prostate-Cancer Test Not Worth Risk, Advisory Panel SaysBloomberg Prostate cancer and the PSA test: It's hard to understand riskLos Angeles Times Men Should Skip Common Prostate Test, Panel SaysWall Street Journal MarketWatch (press release) -New York Times (blog) -ABC News all 294 news articles »

Studies Reveal New Prostate Cancer Mutation Profiles, Subtypes - GenomeWeb

New York Daily News

Studies Reveal New Prostate Cancer Mutation Profiles, Subtypes GenomeWeb By a GenomeWeb staff reporter NEW YORK (GenomeWeb News) – A pair of studies published online yesterday are providing new details about the mutational profiles and pathways that can contribute to prostate cancer. In Nature, a University of Michigan-led ... Scientists discover new type of prostate cancerFox News Scientists find new type of prostate cancer - discovery may lead to tailored ...New York Daily News Scientists Discover Distinct Molecular Subtype of Prostate CancerCornell Chronicle Daily News & Analysis -The Inquisitr all 20 news articles »